Stage IV Major Salivary Gland Cancer AJCC v7
2 clinical trials · Condition
◉ Watch Stage IV Major Salivary Gland Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors (NCT00859937) | National Cancer Institute (NCI) | 2009-03-16 |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT00588770) | National Cancer Institute (NCI) | 2008-08-08 |
Track Stage IV Major Salivary Gland Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.